Doha, Qatar: A recent research study conducted by members of Qatar University’s (QU) Health Sector titled “Pathogenic Homocystinuria-Associated T236N Mutation Dramatically Alters the ...

Travere Therapeutics has voluntarily paused subject enrolment in the Phase III HARMONY Study of pegtibatinase to treat ...